Disorganizing-fibrosing processes in alveolar walls of interstitial pneumonia, "alveolopneumonitis": A morphopathological study.

Fujimoto, Teruo; Matsumoto, Takafumi; Shoji, Shigeichi

doi:10.1620/tjem.158.237

Cited by 3 publications

(1 citation statement)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In contrast with the findings in skin HMVECs, lung HMVECs have been demonstrated to proliferate in 2028 XIANG ET AL bleomycin-induced pulmonary fibrosis in rats (36), in SSc patients with fibrosing alveolitis (37,38), and in SSc patients with pulmonary hypertension (39). We found that HMVECs from a lung cell line showed a higher frequency of proliferative responses to DRC3f and C3f than did HMVECs from a skin cell line.…”

Section: Discussionmentioning

confidence: 94%

Comprehensive investigation of disease‐specific short peptides in sera from patients with systemic sclerosis: Complement C3f‐des‐arginine, detected predominantly in systemic sclerosis sera, enhances proliferation of vascular endothelial cells

Xiang¹,

Matsui²,

Matsuo³

et al. 2007

Arthritis & Rheumatism

View full text Add to dashboard Cite

Objective. To identify pathogenic and/or diseasespecific short peptides in sera from patients with systemic sclerosis (SSc).Methods. Serum samples from 40 patients with SSc, 30 patients with systemic lupus erythematosus, 21 patients with rheumatoid arthritis, 30 patients with osteoarthritis, and 26 healthy donors were tested. Short peptides with molecular weights of smaller than ϳ3 kd, purified from the sera by magnetic bead-based hydrophobic interaction chromatography 18, were detected and their amino acid sequences determined using matrix-assisted laser desorption ionization-time-offlight mass spectrometry. Effects of the identified peptides on fibroblasts and microvascular endothelial cells were tested using synthesized peptides and sera containing the peptides.

show abstract

Section: Discussionmentioning

confidence: 94%